Skip to main content

Table 6 The number and the incidence rate (%) of postoperative nausea and vomiting in the two groups

From: Prospective investigation of intravenous patient-controlled analgesia with hydromorphone or sufentanil: impact on mood, opioid adverse effects, and recovery

 

Group S (n = 37)

Group H (n = 35)

Nausea

Vomiting

Nausea

Vomiting

up to T0

0 (0%)

0 (0%)

1 (2.9%)

0 (0%)

T0−T1

2 (5.4%)

1 (2.7%)

10 (28.6%) #

4 (11.4%)

T1−T2

8 (21.6%)

5 (13.5%)

12 (34.3%)

5 (14.3%)

T2−T3

5 (13.5%)

3 (8.1%)

8 (22.9%)

3 (8.6%)

T3−T4

5 (13.5%)

1 (2.7%)

9 (25.7%)

4 (11.4%)

T4−T5

3 (8.1%)

1 (2.7%)

7 (20.0%)

2 (5.7%)

T5−T6

3 (8.1%)

2 (5.4%)

8 (22.9%)

3 (8.6%)

T6−T7

3 (8.1%)

2 (5.4%)

8 (22.9%)

3 (8.6%)

T7−T8

3 (8.1%)

1 (2.7%)

3 (8.6%)

2 (5.7%)

T8−T9

1 (2.7%)

1 (2.7%)

2 (5.7%)

3 (8.6%)

  1. Values are expressed as number of patients (%). T0: discharge from PACU; T1: 6 h after surgery; T2: 12 h after surgery; T3: 24 h after surgery; T4: 36 h after surgery; T5: 48 h after surgery; T6: 60 h after surgery; T7: 72 h after surgery; T8: 84 h after surgery; T9: 96 h after surgery
  2. #P < 0.05 compared with group S